Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 6/21/2018 |
| Start Date: | October 2012 |
| End Date: | June 2018 |
The purpose of this study is to determine if Contrast Enhanced Spectral Mammography (CESM)
will be able to detect smaller/earlier breast cancers as well as breast MRI can.
will be able to detect smaller/earlier breast cancers as well as breast MRI can.
Inclusion Criteria:
- Women considered at increased risk for developing breast carcinoma (those with a
lifetime risk of >15%due to family history, genetic predisposition, prior radiation
therapy to the chest, prior biopsy showing a high risk lesion, or personal history of
breast cancer) that are being screened with breast MRI.
- Women who have a screening digital mammogram on the day of CESM or within 365 days
prior
Exclusion Criteria:
- Women under 21.
- Pregnant or possibly pregnant.
- Women who have a contraindication to the intravenous use of iodinated - contrast agent
(i.e., allergy to iodinated contrastor severely impaired renal function with a
creatinine level > or = to 1.3).
- Women with breast implants.
- Women with pacemakers.
- Women with aneurysm clips that don't allow for MRI.
- Women too claustrophobic to undergo MRI.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
